Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
US FDA Staff Questions Confirmatory Trial Data for Intercept’s Liver Disease Drug
(Reuters) -Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the effectiveness of Intercept’s liver disease drug, which received the health regulator’s accelerated nod in 2016. Under the accelerated pathway, companies…
English